- Home
- CLDX vs BHE Comparison
CLDX vs BHE Comparison
Compare CLDX & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | BHE |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CLDX | BHE |
|---|---|---|
| Price | $38.43 | $74.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $46.60 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 678.9K | 292.4K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.91 |
| Revenue | $12,743,000.00 | ★ $2,659,108,000.00 |
| Revenue This Year | $111.39 | $7.03 |
| Revenue Next Year | $235.85 | $6.57 |
| P/E Ratio | ★ N/A | $79.81 |
| Revenue Growth | ★ 87.78 | 0.11 |
| 52 Week Low | $22.10 | $35.97 |
| 52 Week High | $45.14 | $100.41 |
Technical Indicators
Market Signals| Indicator | CLDX | BHE |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 44.22 |
| Support Level | $28.51 | $72.31 |
| Resistance Level | $40.30 | $86.86 |
| Average True Range (ATR) | 1.37 | 2.12 |
| MACD | -0.29 | 0.52 |
| Stochastic Oscillator | 31.63 | 43.00 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia, and Europe, of which key revenue is derived from the Americas.